ABSTRACT ACTH inhibits DNA synthesis in normal rat and mouse tumor Y-1 adrenocortical cells within the same concentration range that it stimulates steroidogenesis . These processes can be independently regulated as demonstrated by the divergent actions of cytochalasin B on these cells.
ACTH plays a major role in regulating acute steroidogenesis and maintaining differentiated function of the adrenal gland. Although prolonged administration in vivo has been reported to increase adrenal DNA content (9, 11, 16) , this may not be a direct effect of ACTH because other evidence (3, 4) indicates that ACTH causes hypertrophy rather than hyperplasia of the gland. We have recently shown (12) that in unilaterally adrenalectomized rats, administration of specific ACTH antiserum had no effect on the increase in DNA content and cell proliferation of the remaining adrenal gland. Furthermore, our studies in vitro have demonstrated that ACTH inhibits DNA synthesis and cell replication in normal rat adrenocortical cells (25) as it does in the mouse tumor Y-1 cells (17) . We have now studied the regulation of steroidogenesis and DNA synthesis in both normal and tumor adrenocortical cells in vitro . To investigate whether these processes are necessarily linked, we have used cytochalasin B, an agent that disrupts microfilaments (32) and that has recently been reported to stimulate steroidogenesis in Y-1 cells in the presence of serum (6) but to inhibit the steroidogenic action of ACTH in the absence of serum (21) . We report that the normal rat adrenocortical cells respond very differently to cytochalasin B than do the Y-1 cells, in terms of both steroidogenesis and DNA synthesis .
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MATERIALS AND METHODS

Materials
Highly purified porcine ACTH was prepared as previously described (2) . The cytochalasins, obtained from Sigma Chemical Co . (St. Louis, Mo .), were dissolved in 95% ethanol as stock solutions and then appropriately diluted into the incubation medium. In all cases, ethanol controls were run and the final concentration of ethanol was always lower than 0.25%. Sera, mycostatin suspension, and media were purchased from Grand Island Biological Co . (Grand Island, N.Y.) . Gentamicin was purchased from Schering Corp . (Kenilworth, N.J.), collagenase (170 U/mg) was obtained from Worthington Biochemical Corp. (Freehold, N.J .), and DNAse (410 Kunitz U/mg) was obtained from Sigma Chemical Co . Tissue culture dishes were acquired from Falcon Plastics (Oxnard, Calif) . Radiochemicals were purchased from New England Nuclear (Boston, Mass.), and PCS liquid scintillation fluid was purchased from Amersham Corp . (Arlington Heights, Ill .) . BSA (bovine serum albumin fraction V, purchased from Miles Laboratories, Inc. (Elkhart, Ind.), was purified as previously described (27) .
Cell Culture
Normal adrenocortical cells were isolated from the adrenal glands of adult male Sprague-Dawley rats (140-180 g) by digestion with collagenase and DNAse as previously described (25) . The cells were suspended in medium 199 D-valine containing 10% dialyzed fetal calf serum, gentamicin (40 fag/ml) and Mycostatin (20 U/ml) and plated in 2-cm' multiwells at a density of 105 cells/ml per well . The results shown were obtained from experiments carried out 7 d after plating the cells . Similar results were obtained with cells 5 d after plating.
The mouse adrenal tumor cell line Y-1, introduced in culture by Buonassisi et al . (l) , was obtained from the American Type Culture Collection (Rockville, Md .) . Cells were grown as monolayers in 75-cm' plastic tissue culture flasks (20 x 106 cells/flask) in Ham's F-l0 medium containing 15% horse serum, 2.5% fetal calf serum, and 30 ILg/ml gentamicin. Cells were subcultured once a week using trypsin (0 .05% in normal saline, containing 0.02% EDTA). They were resuspended in medium and serum and plated 2-cm' multiwells at a density of 2 x 105 cells/ml per well. The results shown were obtained from experiments carried out 24 h after plating cells . Similar results were obtained with cells 5 d after plating.
All cells were maintained at 37°C in a humidified atmosphere of 5% COz in air, and the medium was replaced every 2-3 d. Under these conditions, the Y-I cells doubled every 24 h, whereas the normal cells had a doubling time of 48 h.
Steroid Measurement
Cells were incubated in 1 ml of medium under the conditions stated in the figure legends . 50-Al aliquots of medium were removed at the end of the incubation and stored frozen at -20°C until assayed for steroid content. A specific radioimmunoassay for corticosterone described previously (12) was used to measure steroid output from the normal cells . The major steroid produced by the Y-1 cells is 20a-dihydroprogesterone (22, 15) . This was also measured by a specific radioimmunoassay which gave a <0.01% cross-reactivity with cortisol, corticosterone, progesterone, and 17a-hydroxyprogesterone and a 0.03% crossreactivity with testosterone.
Measurement of [ 3 H]Thymidine Incorporation
For these measurements the medium that was considered to be the most suitable for maintenance and growth of each cell type was used . Thus, the results shown were obtained using medium 199 13-valine with 10% dialyzed fetal calf serum (FCS) for the normal cells and Ham's F-10 with 15% horse serum (HS) and 2.5% FCS for the Y-1 cells.
Cells were incubated in I ml of medium in the presence or absence of hormones at 37°C . [methyl-'H]thymidine (5 Ci/mmol; 5 ACi/ml per well) was added and incubations were continued for the times stated in the figure legends. The reactions were terminated within 20 s by rapid washing of the cells with 1 ml ice-cold Dulbecco's phosphate-buffered saline (PBS) and immediate addition of I ml TCA (10% wt/vol) at O'C and dissolved in 0.5 ml of 0.1 N NaOH by incubating at 37°C for I-2 h. An aliquot was mixed with PCS scintillation fluid and counted in a Packard Tri-carb 3320 scintillation counter (Packard Instrument Co ., Inc., Downers Grove, 111 .)
Measurement of [ 3 H]Thymidine Uptake
Cells were incubated at 37°C in 1 ml of medium (see above) containing [methyl-''H)thymidine, under the conditions stated in the figure legends. Reactions were terminated effectively within 20 s, by rapid washing of the cells with I ml of PBS at 0°C and immediate addition of 500 gl of sodium dodecyl sulfate (10% wt/vol) . Total cell material was completely solubilized during a I-2-h period at 37°C . Theamount of radioactivity takenup was determined by counting an aliquot of the solubilized material. In the Y-1 cells ( Fig. 1 B) , cytochalasin B increased steroidogenesis two to threefold, in the presence of serum, over a 1-24-h incubation . The results of an 8-h incubation are shown in (Fig. 4 C and D) .
RESULTS
Actions of Cytochalasin B ST E RO ID O G E N ES IS
We have also investigated whether the characteristic morphological changes produced by both ACTH (33, 25) 
Divergent Effects of Cytochalasin B on ACTH-stimulated Steroidogenesis
In the normal rat adrenocortical cells incubated in the presence of serum (Fig. 3) , cytochalasin B partially inhibited ACTH-stimulated steroidogenesis. This inhibitory effect was also seen in various serum-free media (Ham's F-10 with 0.5% BSA; medium 199 with 0.5% BSA; PBS with 0 .5% BSA).
In the Y-1 cells, cytochalasin B had no effect on ACTHstimulated steroidogenesis in serum-containing media (Ham's F-10 with 15% HS, 2.5% FCS or medium 199 D-valine with 10% dialyzed FCS), although it inhibited the stimulation by ACTH in serum-free media (data not shown) .
Effects of Cytochalasin B on ACTH Inhibition of 
When ACTH and cytochalasin B were added to the cells at the same time, the highest concentrations of ACTH were able to increase the maximum inhibition produced by cytochalasin B alone, in both cell types, although the combined effects were not additive (data not shown) .
Actions of Cytochalasin B on Thymidine Uptake and DNA Synthesis
Because cytochalasin B inhibited [3 H]thymidine incorporation into DNA very rapidly in both cell types, we investigated the possibility that this effect may be mediated by inhibition of [3 H]thymidine uptake into the cell. Results of experiments measuring uptake of [3H]thymidine into total cell material are shown in Fig. 4A and B. The kinetics of uptake are very different; in the normal cells (Fig. 4A ) the radioactive pool was saturated within 10 min, whereas in the Y-1 cells (Fig. 4B) there was a continual increase in uptake into the cell, over a 2-h period .
It can be seen that in the normal cells (Fig. 4A ) no inhibitory effect of cytochalasin B on [3H]thymidine uptake was observed . However, in the Y-l cells (Fig. 4 B) , cytochalasin B inhibited [3 H]thymidine uptake into total cell material very rapidly, an effect being observed as early as 2 min. This decreased uptake could explain the rapid inhibition of [3H]thymidine incorporation into DNA by cytochalasin B in these cells (Fig. 4 C and  D) .
Similar results were obtained with Y-1 cells that had been maintained in low serum (0.2% FCS) medium containing 0.5% BSA for 48 h (data not presented) . These cells incorporated less thymidine and had a growth rate which more closely approached that of the normal cells. The thymidine uptake curve obtained showed saturation kinetics, as in the case of the normal cells (Fig. 4, A) . In these Y-I cells, also, the inhibitory effects of cytochalasin B on thymidine incorporation could be explained by a decreased uptake of thymidine into the cell.
In both cell types, ACTH did not inhibit [3 H]thymidine uptake. In the normal cells, control uptake was 1,884 ± 151 cpm (nine observations); in the ACTH (2.2 nM)-treated cells the uptake was 1,819 ± 107 cpm (six observations) after a 2-min incubation . In the Y-1 cells, control uptake was 14,649 ± 487 cpm (five observations) ; in the ACTH (22 nM ACID-INSOLUBLE C -/33-TIME (min intracellular thymidine pool is labeled but no incorporation of thymidine into DNA occurs. On subsequent incubation of the cells at 37°C, incorporation of this intracellular labeled thymidine into DNA occurs . Hence, inclusion of cytochalasin B at this stage will show whether it is directly affecting DNA synthesis. In the normal cells (Fig. 4E) tion, suggesting that DNA synthesis was inhibited. Furthermore, 7 d after plating, the normal cells were treated with control or cytochalasin B (10 LM)-containing medium for 48 h, and the DNA content of the cells was measured by the method of Ceriotti (5, 28) . Control cells contained 1.12 ± 0.16 ,ug DNA, (3) whereas the cytochalasin B-treated cells contained 0.52 ± 0.04 g,g DNA (3). Conversely, in the Y-1 cells no effect of cytochalasin B was observed after prelabeling, suggesting that DNA synthesis was not inhibited. Representative experiments measuring [3H]thymidine incorporation and uptake as described above were carried out with medium 199 D-valine with 10% dialyzed FCS for the Y-1 cells and Ham's F-10 with 15% HS with 2.5% FCS for the normal cells. The effects of cytochalasin B on the two cell types were similar to those already presented (data not shown) . Thus, the marked differences observed in the responses of the two cell types to cytochalasin B were not caused by differences in medium composition or thymidine concentration .
Effects of Cytochalasin D
Cytochalasin D, which is much less potent in inhibiting glucose uptake in various cell types (30) than is cytochalasin B, also inhibited [aH]thymidine incorporation into DNA in the normal cells (Table I) . At lower concentrations, it was more effective than cytochalasin B, although the same maximum effect was produced, suggesting a similar mechanism of action. Cytochalasin D caused morphological changes similar to those produced by cytochalasin B within a 30-min incubation .
DISCUSSION
The mouse adrenal tumor cell line Y-l has been used extensively as a model system to study the mechanisms by which steroidogenesis and DNA synthesis are regulated (17, 25, 6, 31) . However, in the present paper we have shown that the Y-1 cells are not only much less sensitive to ACTH, but also respond very differently to cytochalasin B than do normal rat adrenocortical cells, in culture.
In the normal cells, cytochalasin B did not increase steroidogenesis in the presence or absence of serum and it inhibited the stimulation by ACTH . In the Y-1 cells, we confirm the results of previous studies (21, 6) showing that ACTH-stimulated steroidogenesis was inhibited only in serum-free media, and, in the presence of serum, cytochalasin B increased steroidogenesis . Thus, in the absence of serum, the Y-1 cells repsond in the same way as the normal cells. The mechanism by which cytochalasin B increases steroid output in the Y-t cells is different from that of ACTH, because ACTH stimulation is independent of the serum content of the medium and the maximum effect is greater than that produced by cytochalasin B.
In the normal rat adrenocortical cells, ACTH increases steroidogenesis and decreases ['H]thymidine incorporation into DNA over the same physiological concentration range. It is apparent that these processes can be independently regulated, because cytochalasin B decreased [''H]thymidine incorporation into DNA without increasing steroidogenesis and inhibited ACTH-stimulated steroidogenesis while increasing its inhibitory effect on [''H]thymidine incorporation . The inhibitory effects of both ACTH and cytochalasin B on [''H]thymidine incorporation into the normal cells are the result of decreased DNA synthesis, since we have shown that neither ACTH nor cytochalasin B has any effect on [''H]thymidine uptake into the cell . This would be expected from our previous results (25, 26) showing that ACTH-treated cultures have a lower DNA content and cell number than controls and from our present data showing that the cytochalasin B-treated cultures also contain less DNA than control.
Unlike the effect of ACTH, the inhibition by cytochalasin B of thymidine incorporation into the Y-1 cells can be explained by a decreased uptake of [3H]thymidine into the cell. This is consistent with the rapid effect of cytochalasin B and the fact that ACTH and cytochalasin B together cause a greater effect than the maximum inhibition produced by either agent alone.
It is known (24) that transport of nucleotides and transport of nucleosides have very different characteristics, depending on the cell type . Thus, cytochalasin B inhibits thymidine transport in Chinese hamster ovary cells (8) and Novikoff rat hepatoma cells (23) but not in HeLa cells (20) . In the Y-I cells, it seems likely that cytochalasin B is inhibiting carrier-mediated transport, whereas it is possible that thymidine is entering the normal cells by simple diffusion or is being transported by a carrier system which is insensitive to inhibition by cytochalasin B.
Because cytochalasin B inhibits glucose uptake in a wide variety of cells (24, 20) , we have investigated whether its rapid inhibitory effect on DNA synthesis in the normal cells is mediated by a decrease in glucose uptake . There is some dispute as to whether inhibition of glucose transport by cytochalasin B is competitive (7, 14) or noncompetitive (20, 34) ; however, in physiological media there is probably sufficient glucose available from endogenous stores or by diffusion such that overall glucose metabolism is not significantly altered. In the Y-1 cells (21) and in pituitary tissue (18) , cytochalasin B did not affect ATP concentration during a 2-h incubation . Furthermore, increasing the glucose concentration of the incubation medium of the normal adrenocortical cells from 5.5 to 30 mM did not overcome the inhibitory effect of cytochalasin B on [''H]thymidine incorporation (data not included).
We have also shown that cytochalasin D is more effective at lower concentrations than cytochalasin B in decreasing DNA synthesis in the normal cells. This analogue is much less potent in inhibiting glucose uptake than is cytochalasin B and is totally ineffective in some systems (19, 30) . However, it is more effective in disrupting microfilaments and causes morphological changes similar to those produced by cytochalasin B in adrenocortical cells. Thus, the inhibition of DNA synthesis by cytochalasin B in the normal cells does not appear to be mediated by effects on glucose transport.
The inhibitory actions of both ACTH and cytochalasin B on DNA synthesis in these cells may be mediated by disruption or rearrangement of microfilaments since in both cases morphological changes are observed at the onset of inhibition of DNA synthesis. ACTH decreases DNA synthesis in both normal and tumor adrenocortical cells, whereas cytochalasin B inhibits only in the normal cells. The reason for this is not clear, but it may be related to the fact that cytochalasin B inhibits nuclear division in normal cells (13, 10, 29) but has no effect on a variety of tumor cell types.
